Cardiopatías congénitas y embarazo / Congenital heart disease and pregnancy
Clín. investig. ginecol. obstet. (Ed. impr.)
; 43(1): 24-31, ene.-mar. 2016. tab
Article
in Spanish
| IBECS
| ID: ibc-148451
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
Las cardiopatías congénitas han ido aumentando entre las mujeres embarazadas de los países desarrollados debido a su mayor supervivencia, la tardía edad gestacional, las nuevas técnicas de fecundación y el aumento de los factores de riesgo cardiovascular. Los cambios fisiológicos del embarazo, parto y posparto conllevan un incremento en el volumen plasmático, la frecuencia cardiaca, el gasto cardiaco y un descenso de las resistencias vasculares periféricas. Aunque bien tolerados en las pacientes con corazones estructuralmente sanos, estos cambios pueden conllevar un mayor riesgo de morbimortalidad materno fetal entre pacientes con cardiopatía. De ahí que conocer la fisiopatología del embarazo, los fármacos que pueden ser utilizados, el riesgo de transmisión de la cardiopatía materna al feto o las cardiopatías congénitas que conllevan un mayor riesgo obstétrico resulte fundamental a la hora de realizar una adecuada valoración, seguimiento y tratamiento de la cardiópata gestante
ABSTRACT
Congenital heart disease has increased among pregnant women from developed countries due to their longer survival, later age at pregnancy, new fertilization techniques and increased cardiovascular risk factors. The physiological changes of pregnancy, childbirth and postpartum increase plasma volume, heart rate, and cardiac output and decrease peripheral vascular resistance. Although these changes are well tolerated in patients with structurally healthy hearts, these changes may lead to a greater risk of fetal and maternal morbidity and mortality among patients with heart disease. Therefore, knowledge of the pathophysiology of pregnancy, the drugs that can be used, the risk of maternal transmission of disease to the fetus, and of the congenital heart diseases that pose an increased obstetric risk is essential for the proper assessment, monitoring and treatment of pregnant women with heart disease
Full text:
Available
Collection:
National databases
/
Spain
Health context:
SDG3 - Health and Well-Being
/
SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases
/
SDG3 - Target 3.2 Reduce avoidable death in newborns and children under 5
Health problem:
Target 3.1: Reduce maternal mortality
/
Target 3.2: Reduce avoidable death in newborns and children under 5
/
Cardiovascular Disease
/
Congenital and Chromosomal Anomalies
/
Other circulatory Diseases
/
Environmental Health
/
Neonatal Healthcare
/
Noncommunicable Diseases
Database:
IBECS
Main subject:
Pregnancy Complications, Cardiovascular
/
Heart Defects, Congenital
Type of study:
Etiology study
/
Risk factors
Limits:
Female
/
Humans
/
Pregnancy
Language:
Spanish
Journal:
Clín. investig. ginecol. obstet. (Ed. impr.)
Year:
2016
Document type:
Article
Institution/Affiliation country:
Complejo Hospitalario Universitario Insular Materno Infantil/España
/
Hospital Universitario de Gran Canaria Dr. Negrín/España